Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) (TAHHT)
This study has been completed.
Sponsor:
University Hospital, Saarland
Collaborators:
Pharmacia GmbH, Erlangen, Germany
Baxter Healthcare Corporation
Information provided by:
University Hospital, Saarland
ClinicalTrials.gov Identifier:
NCT01031992
First received: December 11, 2009
Last updated: December 12, 2009
Last verified: December 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | October 2002 |
| Primary Completion Date: | August 2002 (Final data collection date for primary outcome measure) |